For most people, an HPV diagnosis does not prevent natural conception or make having a healthy baby impossible. CDC specifically states that having HPV does not make it harder for a woman to become pregnant or carry a pregnancy to term; the fertility and pregnancy concerns that require closer attention are more often related to significant cervical disease or procedures used to treat it.
That distinction is important for couples planning marriage, pregnancy, or a family.
An HPV diagnosis can make a relatively ordinary family-planning decision feel frightening. You may wonder whether trying to conceive without condoms will make the infection worse, whether HPV can reach the baby, or whether a previous LEEP means you will have a high-risk pregnancy.
The medical picture is more manageable than those fears suggest.
HPV is common, and an HPV diagnosis is not, by itself, a reason to abandon plans for pregnancy. What matters is understanding your current HPV or cervical findings, any previous treatment, and the pregnancy-specific follow-up you actually need.
The Direct Answer: Does HPV Cause Infertility?
Separating Fact from Fear: Conception and HPV
HPV itself is not generally considered a direct cause of female infertility, and most women with HPV can become pregnant and carry a pregnancy. CDC states that HPV infection does not make it harder for a woman to become pregnant or carry a pregnancy to term.
That is the most important starting point.
An HPV-positive result does not mean your eggs have been damaged, your uterus can no longer support a pregnancy, or your reproductive future has been compromised.
However, it is important not to turn that reassurance into an absolute claim that HPV can never be associated with fertility problems.
Some observational studies have reported associations between high-risk HPV and female infertility. A 2020 systematic review and meta-analysis found that high-risk HPV was associated with infertility in the pooled observational data, but the authors specifically concluded that HPV appeared to be a potential risk factor rather than an independent established cause and called for better prospective research.
This is a useful distinction:
Association is not the same as causation.
A person with HPV may also have other reproductive-health factors that affect fertility, and HPV-related cervical disease or treatment can introduce separate considerations.
That is why a positive HPV test should not be interpreted as a fertility diagnosis.
If you are trying to conceive and pregnancy has not occurred after the usual period of attempting, fertility evaluation should consider the full range of reproductive factors rather than assuming HPV is responsible. WHO defines infertility based on failure to achieve pregnancy after 12 months of regular unprotected intercourse and recommends evidence-based evaluation of both partners.
Male Fertility: Does HPV Affect Sperm Quality?
The male-fertility evidence is more complicated than a simple "HPV does not affect sperm" statement.
Several systematic reviews have reported associations between HPV detected in semen and poorer semen parameters, including sperm concentration, motility, or morphology. A 2024 systematic review and meta-analysis of 25 studies involving more than 6,900 participants found lower sperm morphology among HPV-positive men, while other meta-analyses have also reported associations with reduced motility and concentration.
But these studies do not establish that an ordinary genital HPV infection directly causes male infertility in everyday clinical practice.
The evidence includes observational studies with important methodological limitations, and researchers continue to debate how HPV detected in semen translates into actual natural-conception outcomes. Earlier systematic reviews likewise concluded that evidence was not strong enough to define HPV semen infection as a clear clinical cause of infertility.
So for a man planning a family, an HPV diagnosis is not a reason to assume that he cannot father a child.
The better approach is to separate two questions:
"Do I have HPV?"
and
"Do I actually have evidence of impaired fertility?"
They are not the same question.
If a couple has been trying to conceive without success, semen analysis and a standard fertility evaluation are more useful than treating an HPV result as an explanation by default.
Getting Pregnant with HPV: Risks to the Fetus and Pregnancy
Vertical Transmission: Can HPV Pass to Your Baby?
HPV can occasionally be transmitted from mother to infant around pregnancy or delivery, but clinically significant transmission is considered uncommon, and this possibility does not mean that most HPV-positive pregnancies are unsafe. CDC describes transmission to an infant during delivery as rare.
Research has detected HPV DNA in some newborns of HPV-positive mothers, but interpretation is complicated. Detecting HPV DNA immediately after birth does not necessarily prove a persistent infection in the infant; contamination or transient exposure around delivery can also occur.
There is also a rare association between HPV types 6 and 11 and recurrent respiratory papillomatosis in children. CDC considers this uncommon and notes that the exact route of transmission is not fully understood. Importantly, cesarean delivery is not recommended solely to prevent HPV transmission to the newborn.
This gives couples an important practical perspective:
Having HPV does not mean your baby is destined to become infected or develop an HPV-related condition.
It also does not mean pregnancy should automatically be postponed simply because an HPV test is positive.
For most pregnancies, obstetric care remains focused on routine prenatal monitoring plus any additional follow-up required by the mother's cervical findings.
Miscarriage and Preterm Birth: What the Science Says
The relationship between HPV and pregnancy outcomes is more nuanced than the idea that "HPV causes miscarriage."
Several systematic reviews and meta-analyses have found associations between maternal HPV infection and outcomes such as preterm birth or premature rupture of membranes. For example, a 2020 meta-analysis found associations with preterm birth, preterm premature rupture of membranes, low birth weight, and fetal death, but it also emphasized that many included studies were of moderate or low quality and that substantial heterogeneity remained.
More recent evidence remains mixed. A 2024 meta-analysis found an association between HPV infection and preterm delivery but did not find a significant association with spontaneous abortion, and the authors called for better control of confounding factors.
That means it would be medically inaccurate to tell an HPV-positive pregnant person:
"HPV causes miscarriage."
It would also be inaccurate to promise that HPV can never influence pregnancy outcomes.
The clinically responsible interpretation is that HPV alone is usually not treated as a reason to avoid pregnancy, but a pregnant person with HPV should follow appropriate prenatal and cervical follow-up rather than ignoring an abnormal result.
ASCCP guidance explains that pregnancy does not change the natural history of HPV and that abnormal cervical screening should still be managed according to risk-based thresholds. When clinically indicated, colposcopy and biopsy can be performed during pregnancy, while treatment of cervical precancer is generally deferred unless cancer is suspected.
That is very different from viewing an HPV-positive pregnancy as a medical emergency.
Trying to Conceive (TTC) Without Condoms: Managing the Risks
Does Unprotected Sex Make HPV Worse?
Trying to conceive necessarily means that a couple will stop using condoms for the sexual activity intended to achieve pregnancy.
There is no standard clinical recommendation that a monogamous couple must continue using condoms solely to prevent an established HPV infection from becoming "stronger" during conception.
Condoms can reduce HPV transmission, but their role is different when both partners are in an established relationship and are deliberately trying to conceive. They may still be useful for reducing exposure to other sexually transmitted infections when relevant, but pregnancy cannot be achieved through barrier-protected intercourse in the same way.
There is also no evidence-based concept of "HPV accumulating" in a couple simply because they stop using condoms to conceive.
The more important issue is whether either partner has an active condition that needs medical attention.
If one partner has visible genital warts, significant cervical abnormalities, unexplained genital symptoms, or another infection, the appropriate management should be discussed with a healthcare professional rather than assuming that conception should proceed without regard to those findings.
And if pregnancy does not occur, do not automatically blame repeated HPV exposure.
Fertility is influenced by many factors, including ovulation, age, sperm factors, tubal function, uterine factors, and other medical conditions. WHO recommends evaluating infertility as a condition involving either or both partners rather than attributing it to a single suspected cause without evidence.
Timing Conception Around HPV Pap Tests and Biopsies
A sensible family-planning strategy is to review your cervical-health history before trying to conceive.
That does not mean every person with HPV needs a special fertility clearance.
It means you should know whether your most recent screening was routine, whether there is an unresolved abnormal result, and whether your clinician has recommended additional evaluation.
If a screening result indicates significant cervical abnormalities, treatment decisions should be made before pregnancy when appropriate.
Once pregnancy occurs, management changes. ASCCP states that pregnancy does not accelerate HPV's natural history and that expedited treatment of cervical abnormalities is not recommended during pregnancy; excision is reserved for situations in which cancer is suspected.
This is why a useful preconception checklist is simple:
Know your latest cervical-screening result.
Complete any recommended evaluation.
Tell your obstetric provider about previous abnormal results or cervical procedures.
Then build the pregnancy plan around the actual findings rather than the HPV label alone.
You do not need to wait for an HPV test to become negative before every pregnancy attempt.
The relevant question is whether there is a condition that needs treatment or surveillance.
Pregnancy After Cervical Procedures (LEEP / Cone Biopsy)
How Cervical Treatments Impact Pregnancy
The distinction between HPV infection and treatment for HPV-related cervical precancer becomes especially important here.
HPV itself usually does not prevent pregnancy. However, procedures used to remove cervical precancer—such as LEEP or cone biopsy—can slightly increase the risk of certain pregnancy complications.
ACOG states that LEEP may be associated with a small increase in premature birth and low birth weight, although most women have no pregnancy problems after the procedure.
This does not mean that a previous LEEP makes pregnancy unsafe.
It means your pregnancy history includes an additional factor that your obstetric team should know about.
The depth and amount of cervical tissue removed can matter, and repeated or extensive cervical excisional procedures may carry greater concern than a small single procedure.
The timing question also needs nuance.
There is no universal rule that every person must wait exactly three, six, or twelve months after a LEEP before attempting pregnancy. The cervix needs time to heal, and your follow-up plan may influence when your clinician considers it appropriate to try.
ACOG notes that cervical healing takes several weeks and that intercourse should be avoided during the immediate recovery period as instructed by the treating clinician.
Some healthcare systems recommend waiting until the first post-treatment follow-up test before trying to conceive; for example, NHS patient guidance commonly schedules a follow-up test around six months after treatment. This is a follow-up strategy rather than a universal biological "fertility waiting period."
So if you have had LEEP or cone biopsy, the most useful question for your doctor is not:
"What is the universal number of months I must wait?"
It is:
"Has my cervix healed, is my post-treatment follow-up complete, and based on the depth and extent of my procedure, when is it appropriate for us to start trying?"
Cervical Length Monitoring During Prenatal Care
A history of cervical surgery is relevant to obstetric planning because cervical tissue can influence the risk of cervical shortening or preterm birth.
But having had a LEEP does not automatically mean every pregnant person needs a cerclage or intensive cervical-length surveillance.
Your obstetrician may consider your procedure history together with previous pregnancies, previous preterm birth, the amount of cervical tissue removed, and ultrasound findings.
When cervical-length assessment is indicated, transvaginal ultrasound is the standard method used to measure the cervix accurately. SMFM identifies a midtrimester cervical length of 25 mm or less as the threshold used to define a short cervix in certain singleton pregnancies without a prior spontaneous preterm birth.
If cervical shortening or other significant risk factors are present, management may include vaginal progesterone or, in selected circumstances, cervical cerclage.
Cerclage is not automatically prescribed simply because someone once had a LEEP. ACOG explains that cerclage decisions depend on factors such as prior pregnancy history, painless cervical dilation, and ultrasound findings.
The practical lesson is reassuring:
A previous LEEP changes what your obstetric team watches; it does not automatically determine how your pregnancy will end.
Delivery Options: Natural Birth vs. C-Section with HPV
Giving Birth Naturally with High-Risk HPV
A high-risk HPV diagnosis by itself is not an indication for cesarean delivery.
A person with HPV 16, HPV 18, or another high-risk type does not normally need a C-section simply because the virus was detected.
CDC guidance focuses instead on the obstetric circumstances and any actual cervical disease. Even the presence of HPV itself is not treated as a reason to perform cesarean delivery purely to prevent neonatal HPV exposure.
This is an important distinction because "high-risk HPV" sounds more serious than it necessarily is in the delivery room.
High-risk describes the type's association with certain cancers when infection persists.
It does not mean that a vaginal birth is inherently unsafe.
If the pregnancy and cervix are otherwise appropriately managed, the delivery route is determined primarily by standard obstetric indications rather than the HPV label.
Managing Genital Warts During Labor
Genital warts require a somewhat different discussion because they can be physically present during pregnancy and may become larger or more fragile.
Even then, genital warts do not automatically require a C-section.
CDC states that cesarean delivery is indicated for anogenital warts when the pelvic outlet is obstructed or when vaginal delivery would be expected to cause excessive bleeding. Cesarean delivery should not be performed solely to prevent HPV transmission to the newborn because its effectiveness for preventing this rare complication is uncertain.
This creates a straightforward decision framework:
Small or manageable warts without obstruction or major bleeding risk → vaginal delivery may remain appropriate.
Warts that obstruct the birth canal or create substantial bleeding risk → cesarean delivery may be considered.
The decision belongs to the obstetric team and depends on what the lesions actually look like at the time of delivery.
Pregnancy can also make genital warts grow or become more friable, so prenatal care should include appropriate evaluation rather than waiting until labor to address significant lesions.
The existence of genital warts therefore does not mean:
"My baby cannot be born naturally."
It means:
"My obstetric team needs to evaluate the actual condition of the birth canal and choose the safest delivery route."
Navigating Long-Term Relationships with HPV
Shift from Panic to Routine Health Monitoring
Once a couple moves from dating into marriage or family planning, HPV becomes much easier to manage when it is treated as one health variable among many, rather than as a permanent relationship crisis.
Instead of repeatedly asking:
"Are we still carrying HPV?"
focus on questions with practical answers:
"Is anyone due for screening?"
"Does either partner have symptoms that need evaluation?"
"Has previous cervical disease been followed appropriately?"
"Are there pregnancy-specific issues our obstetrician needs to know about?"
This approach is especially important because there is no universal test that establishes a person's complete "HPV status." HPV testing is primarily used in cervical cancer screening, and there is no routine HPV screening test recommended for men.
For people undergoing cervical screening in the United States, current ACOG guidance recommends different screening strategies depending on age and circumstances. For example, people ages 30–65 at average risk may use primary high-risk HPV testing every five years, cotesting every five years, or cytology alone every three years depending on the circumstances and test availability. Those with previous abnormalities may need a different follow-up schedule.
That last point is critical.
A person with a history of CIN or cervical treatment should not assume that a routine average-risk screening schedule applies.
The goal is not constant surveillance.
It is appropriate surveillance.
Building a Unified Family Roadmap
Long-term partners can turn HPV management into a shared process rather than an individual source of guilt.
Before conception, review relevant cervical-screening and treatment history.
During pregnancy, make sure the obstetric team knows about previous cervical procedures, significant abnormal results, or active genital warts.
If an abnormal cervical result is discovered during pregnancy, follow the pregnancy-specific monitoring plan rather than assuming immediate treatment is required. ASCCP emphasizes risk-based surveillance during pregnancy and notes that high-grade abnormalities are generally monitored rather than treated during pregnancy unless cancer is suspected.
After delivery, return to the recommended cervical follow-up schedule.
This gives both partners a practical roadmap:
preconception review → prenatal care → appropriate cervical monitoring → delivery planning → postpartum follow-up.
The couple does not need to solve the entire HPV story before having a child.
They need to manage the part that is medically relevant at each stage.
Empowering Your Family Dreams: Science Is on Your Side
Normalizing HPV in the Context of Marriage and Parenthood
HPV is common, and an HPV diagnosis does not revoke someone's right to become a parent.
It does not automatically mean infertility.
It does not automatically mean miscarriage.
It does not automatically mean a premature delivery.
It does not mean a cesarean birth is required.
And it does not mean a child will inevitably acquire an HPV-related disease.
The science is more nuanced than those fears, but that nuance is ultimately reassuring.
CDC explicitly states that HPV does not make it harder for a woman to become pregnant or carry a pregnancy to term. Rare transmission to an infant can occur, while clinically important neonatal complications remain uncommon.
At the same time, responsible family planning means respecting the areas where evidence or risk does matter: significant cervical abnormalities, previous excisional procedures, active genital warts, and pregnancy outcomes that require obstetric monitoring.
That is not a contradiction.
It is what evidence-based care looks like.
Stepping into the Future with Confidence
The healthiest way to approach HPV and family planning is not to pretend that the virus does not exist.
It is to give it the right-sized place in your life.
Know your cervical-health history.
Complete recommended follow-up.
Tell your obstetrician about previous LEEP or cone procedures.
Discuss pregnancy timing after cervical treatment rather than relying on a generic waiting period.
Monitor cervical health according to your individual risk.
And when pregnancy begins, allow your obstetric team to make delivery decisions based on the actual pregnancy—not simply the fact that HPV appears somewhere in your medical history.
For a long-term couple, this changes the emotional question from:
"Will HPV take away our chance to have a family?"
to:
"What information do we need, what monitoring is appropriate, and what decisions do we make together?"
That is a much more powerful position.
HPV can be part of your medical history without becoming the story of your marriage.
It can require screening without requiring fear.
It can require thoughtful pregnancy management without ending the possibility of parenthood.
And it can be one health variable that two committed partners manage together while continuing toward the larger goal that brought them to this stage in the first place:
building a healthy family, with informed choices and realistic confidence.
